Metis Global Partners LLC Acquires 26,080 Shares of Ventas, Inc. $VTR

Metis Global Partners LLC boosted its holdings in Ventas, Inc. (NYSE:VTR) by 28.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 116,974 shares of the real estate investment trust’s stock after buying an additional 26,080 shares during the quarter. Metis Global Partners LLC’s holdings in Ventas were worth $8,187,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cloud Capital Management LLC bought a new stake in shares of Ventas during the third quarter worth $25,000. True Wealth Design LLC lifted its stake in shares of Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after acquiring an additional 405 shares during the last quarter. ORG Partners LLC boosted its holdings in shares of Ventas by 76.1% during the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB grew its position in Ventas by 65.5% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after acquiring an additional 180 shares during the last quarter. Finally, Golden State Wealth Management LLC increased its holdings in Ventas by 52.7% in the 2nd quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 185 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Stock Down 0.5%

Ventas stock opened at $85.26 on Friday. The firm has a market capitalization of $40.50 billion, a price-to-earnings ratio of 157.89, a price-to-earnings-growth ratio of 2.09 and a beta of 0.77. The firm’s fifty day moving average price is $78.45 and its two-hundred day moving average price is $73.68. Ventas, Inc. has a 1-year low of $60.08 and a 1-year high of $87.20. The company has a current ratio of 0.67, a quick ratio of 0.32 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm earned $0.81 EPS. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities research analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a $0.52 dividend. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Ventas’s payout ratio is presently 355.56%.

Insider Activity at Ventas

In other news, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Debra A. Cafaro sold 41,294 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $79.01, for a total value of $3,262,638.94. Following the sale, the chief executive officer owned 1,145,695 shares in the company, valued at approximately $90,521,361.95. This represents a 3.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 96,868 shares of company stock worth $7,574,022. Insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on VTR shares. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. UBS Group restated a “neutral” rating and set a $85.00 price objective on shares of Ventas in a research report on Monday. Scotiabank lifted their price objective on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 13th. Wells Fargo & Company increased their target price on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Finally, KeyCorp raised their price target on shares of Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $85.38.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.